Jeffrey Infante, MD
SCRI Development Innovations, LLC
4
4
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Patricia LoRusso, DO
Barbara Ann Karmanos Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Roger Cohen, MD
Fox Chase Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Judith Ochs, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Lia Gore, MD
University of Colorado, Denver
Shared therapeutic areas:
Worked with same sponsors:
Tony Reid, MD
University of California, San Diego
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
lin shen
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Norman Wolmark, MD
NSABP Foundation Inc
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918
Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects
A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001
All 4 trials loaded